Abbott Laboratories (NYSE:ABT) Lowered to Buy Rating by StockNews.com
Abbott Laboratories (NYSE:ABT – Get Free Report) was downgraded by equities researchers at StockNews.com from a “strong-buy” ...
Jim Cramer on Abbott Laboratories (ABT): ‘Big Position For The Trust’
Jim Cramer, host of Mad Money, recently offered some important advice on how young people should approach investing and ...
Is Abbott Laboratories (ABT) the Best Medical Device Stock to Buy?
We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are ...
Invest with Confidence: Intrinsic Value Unveiled of Abbott Laboratories
In this article, we will take a look into Abbott Laboratories's (NYSE:ABT) DCF analysis, a reliable and data-driven approach ...
Abbott Laboratories stock underperforms Thursday when compared to competitors
The stock's fall snapped a three-day winning streak.
Jim Cramer on Lawsuit Against Abbott Laboratories (ABT): ‘Dismiss It, Not Worry About It’
In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against the other stocks Jim ...
Why We Chose Abbott Labs Stock Amid Tariff And DeepSeek Volatility
The last few weekends have been roiled by headlines. Here's why we took a different direction on this medical stock this week ...
pharmaphorum22h
A history of Abbott and AbbVie
This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...